Metabolic Biomarkers
In a comparable published case, fasting insulin was 87.9 µU/mL — approximately 25 times normal — confirming insulinoma biochemically at first presentation. In insulinoma, fasting insulin runs approximately 20–40 times the normal fasting le…
1 sources - 5 claims
In a comparable published case, fasting insulin was 87.9 µU/mL — approximately 25 times normal — confirming insulinoma biochemically at first presentation. In insulinoma, fasting insulin runs approximately 20–40 times the normal fasting level. A1C reflects average blood glucose over 2–3 months, and an extremely low A1C in someone presenting with obesity or postpartum symptoms signals chronic hypoglycemia rather than hyperglycemia. Measuring blood glucose, ketones, and insulin together takes minutes, costs very little, and immediately narrows the differential diagnosis. Measuring fasting insulin and A1C before a significant dietary intervention provides a baseline and can catch pre-existing conditions like insulinoma before they produce a crisis.